Goodyear Tire & Rubber (NASDAQ:GT – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $9.00 to $10.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock. Other equities analysts have also issued research reports about the stock. TD Cowen cut […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 2 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 3 | Genpact (NYSE:G) Price Target Raised to $45.00 | 0 | 14.26 | 10-08-2026 |
| 4 | Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00 | 0 | 13.83 | 10-08-2026 |
| 5 | Cadre (NYSE:CDRE) Price Target Raised to $45.00 | 0 | 13.85 | 10-08-2026 |
| 6 | Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00 | 0 | 14.22 | 10-08-2026 |
| 7 | Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00 | 0 | 12.25 | 10-08-2026 |
| 8 | Maplebear (NASDAQ:CART) Price Target Raised to $62.00 | 0 | 13.46 | 10-08-2026 |
| 9 | Cabot (NYSE:CBT) Price Target Raised to $78.00 | 0 | 14.69 | 10-08-2026 |
| 10 | Qiagen (NYSE:QGEN) Price Target Raised to $50.00 | 0 | 14.26 | 10-08-2026 |